Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Mitomycin × 1 year × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 10 Non-Muscle Invasive Bladder Neoplasms 9 Anus Neoplasms 6 Colorectal Neoplasms 5 Appendiceal Neoplasms 5 Peritoneal Neoplasms 4 Carcinoma, Transitional Cell 3 Stomach Neoplasms 2 Pseudomyxoma Peritonei 2 Ovarian Neoplasms 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Neoplasm Metastasis 1 Necrosis 1 Nasopharyngeal Carcinoma 1 Mediastinal Neoplasms 1 Lung Metastases 1 Locally Advanced Anal Canal Cancer 1 Liver Neoplasms 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Epstein-Barr Virus Infections 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡